Navigation Links
Case Western Reserve finds mechanism underlying alt. splicing of premessenger RNA into messenger RNA
Date:12/24/2008

CLEVELAND December 24, 2008 An international research team led by Tim Nilsen, Ph.D., a professor of medicine and biochemistry and the director of the School of Medicine's Center for RNA Molecular Biology, has discovered an unexpected mechanism governing alternative splicing, the process by which single genes produce different proteins in different situations. The new mechanism suggests that curing the more than half of genetic diseases that are caused by mutations in the genetic code that in turn create mistakes in alternative splicing may be considerably more complicated than biomedical researchers have previously assumed. Those diseases include a large number of cancers and many neurodegenerative diseases.

The research, titled "Dynamic regulation of alternative splicing by silencers that modulate 5' splice site competition" is published in the December 24 issue of Cell. Nilsen led an international team of researchers from Case Western Reserve University, Columbia University, Memorial Sloan-Kettering Cancer Institute in New York City, and the Max Planck Institute for Biophysical Chemistry in, Germany. Case post-doctoral fellow Yang Yu, Ph.D. was the lead author.

"Regular" splicing is the process by which long strings of nucleotides in a gene's pre-messenger RNA (pre-mRNA) are discarded, and the remaining strings of nucleotides are spliced together into one continuous strand of messenger RNA (mRNA) that produces one unique protein.

But regular splicing is insufficient to produce all the proteins in the human cell, where 25,000 genes surprisingly produce more than 100,000 proteins. The additional 75,000 proteins are created by alternative splicing, a process that selectively activates alternate splicing sites along the pre-messenger RNA strand to assemble different subsets of RNA nucleotides into a variety of mRNA's. Each mRNA then produces a single protein. The vast majority of genes utilize alternative splicing.


'/>"/>

Contact: Christina DeAngelis
christina.a.thompson@case.edu
216-368-3635
Case Western Reserve University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Western diet linked to increased risk of colon cancer recurrence
2. UT Southwestern researchers identify hundreds of genes controlling female fertility
3. Northwestern to expose most deadly infectious diseases in 3-D
4. Northwestern study looks at sensing, movement and behavior
5. Tiny dust particles from Asian deserts common over western United States
6. Threatened bird species finds home at Western
7. BMI criteria for obesity surgery should be lowered, UT Southwestern researcher suggests
8. UT Southwestern secures $5 million NIH grant for lupus research
9. UT Southwestern scientist honored among best in Texas research
10. Western Groundfish Conference to be held in Santa Cruz on Feb. 4-8
11. Stem-cell transplantation improves muscles in MD animal model, UT Southwestern researchers report

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ased to announce the publication of results from i...acy and tolerability of its novel, intranasal drug...ic rhinosinusitis with nasal polyps in Rhinology ...ropean Rhinologic Societies. , Chronic rhinosin... can significantly reduce a patient,s quality of l...
(Date:12/1/2009)...sity cancer researchers have developed a tumor-at...d blocks the growth of new tumor blood vessels. ,...ll cancer cells oncolytic viruses might be more ...also carry a gene for a protein that inhibits bloo...tin, is normally produced in the brain. In this st...
(Date:12/1/2009)...tacks by sharks can be solved with a new technique...they put on their victims, according to a Universi...a method analogous to analyzing human fingerprints... comparing shark bites to the jaws and teeth of th...r of the International Shark Attack File, which is...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Tumor-attacking virus strikes with 'one-two punch' 2New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen 50666 1Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen 50666 2Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 1Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 2Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 3Partnership for Prescription Assistance Prepared to Help North Dakota Workers Hurt by Recession 50664 4If 2 Painkillers Are Banned What Next 3F 50662 1If 2 Painkillers Are Banned What Next 3F 50662 2If 2 Painkillers Are Banned What Next 3F 50662 3If 2 Painkillers Are Banned What Next 3F 50662 4
...entists working in an ice-free region of Antarctic...e form of fossilized plants and insects--on the in...atures began a relentless drop millions of years a... degrees Celsius, over a relatively brief period o...rced the extinction of tundra plants and insects a...
... traditionally focused on protecting individual sp...ring, however, that preserving the benefits that w...ally and environmentally valuable. At the Annual M... ecologists will explore the application of ecosys...tem services are the benefits that humans reap fro...
... professor and Georgia Research Alliance Eminent S...eorgia, has been awarded $9.2 million as part of a...e of General Medical Sciences, part of the Nationa...rtered in the department of biochemistry and molec...ings of the early steps that stem cells take in be...
Other Biology News:Antarctic fossils paint a picture of a much warmer continent 2Antarctic fossils paint a picture of a much warmer continent 3Antarctic fossils paint a picture of a much warmer continent 4Antarctic fossils paint a picture of a much warmer continent 5Evaluating ecosystem services 2Evaluating ecosystem services 3UGA researchers win $9.2 million stem cell grant from NIH 2
(Date:12/2/2009)...swire/ -- S*BIO Pte Ltd today announced data prese... at The American Society of Hematology 51st Annual... will be presented on the clinical results from th...g its safety, tolerability and pharmacokinetic/pha...g from 100 to 600 mg. These doses were administere...
(Date:12/2/2009).../PRNewswire-Asia/ -- Simcere Pharmaceutical Group,...ding pharmaceutical company,specializing in the de...,generic and proprietary pharmaceuticals in China,...ncluded in China,s National Drug Reimbursement Lis...f Human Resources and Social,Security on November ...
(Date:12/2/2009)...swire-Asia/ -- The world is going through,extraord...y is part of many,businesses and industries. It tu...ly immune to the economic downturn, because illnes...idst of the difficult times this year, the pharmac... R&D center in Shanghai, the largest of,its ki...
(Date:12/2/2009)...wire/ -- According to the National Institute of He...sed with diabetes already have some stage of diabe...the retina caused by leaky blood vessels, is a maj...is one of the most feared diabetic complications. ...had diabetes for 10 years or more will experience ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...t. 8 Wyeth Pharmaceuticals, a,division of Wyeth (...ts have,begun for XYNTHA(TM) Antihemophilic Factor...ant factor VIII product for both the,control and p...laxis in,patients with hemophilia A, a rare, inher... using state-of-the-art manufacturing and,purifica...
...wswire-FirstCall/ - Oncolytics Biotech Inc.,("Onco...at that it has,started patient enrolment in a Phas...n of REOLYSIN(R) in combination with paclitaxel an...eck cancers. The Principal,Investigator is Dr. Mon...CTRC) at The University of Texas Health Science Ce...
...rescriber, Software Simplifies Medicare - For Free...,announced the latest release of their PlanPrescri...o longer need to worry about whether they are,gett...ns. PlanPrescriber,the brainchild of MIT Professor... advice to help seniors quickly find their best Me...
Other Biology Technology:New Recombinant XYNTHA Now Available for Patients with Hemophilia A 2New Recombinant XYNTHA Now Available for Patients with Hemophilia A 3New Recombinant XYNTHA Now Available for Patients with Hemophilia A 4New Recombinant XYNTHA Now Available for Patients with Hemophilia A 5Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 3On-Line Medicare Advisor Saves Seniors Time, Hassle and Money 2
Goat Anti-Human EML1 (K-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
BCASMC (B350-05) from European Collection of Cell Cultures (ECACC)
BAOSMC (B354-05) from European Collection of Cell Cultures (ECACC)
Adaptor for ABI 3700 (AB-0800) from ABgene
Biology Products: